Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT06952842
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Phase 3
Recruiting
- Conditions
- Bietti Crystalline Corneoretinal DystrophyBietti Crystalline Dystrophy
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT06743646
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Harbin Medical University, Haerbin, Heilongjiang, China
Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT05832684
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳West China Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Tianjin Medical University Eye Hospital, Tianjin, Tianjin, China
© Copyright 2025. All Rights Reserved by MedPath